Lexicon Pharmaceuticals, Inc. Stock: price and insider trades · United States

Lexicon Pharmaceuticals, Inc., classified in the Health Care sector, is a listed company based in The Woodlands, United States, founded in 1995. Its insiders report their share dealings to SEC (Form 4). 14 insiders have disclosed 18 filings since 18 October 2025.

Every open-market trade in the period is a purchase: 4 purchases worth €252k, from 1 insider, and not a single sale. Unlike grants, an open-market purchase is paid for by the insider, at the market price. One trade stands out by size: a purchase of €124k from Debbane Raymond, disclosed on 25 February 2026. Among those who bought: 1 senior executive.

Compared with its exchange (5,808 companies, median 19 filings), a count of 18 filings is below the norm. The full history, which starts in 2022, counts 20 purchases against no sales. On the fundamentals side, the SEC filing (10-K) for the period ending 31 December 2025 lists revenue at 49.8 m USD and net income at -50.3 m USD.

The last insider purchase was made public on 27 February 2026, 233 days ago. The median gap between a trade and its publication by SEC (Form 4) is 3 days. US insiders must file a Form 4 within two business days of a trade.

For comparison within the same sector, see the insider buying recorded at Cooper Companies, Inc. and Cytosorbents Corp. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.